Further studies are actually needed to ascertain whether plasma levels of AGEs, sRAGE, HMGB1, and S100 proteins in DM COVID-19 patients are differentially affected by conventional vs. intensive insulin therapy and are predictive of patients' outcome. The gene discussed is HMGB1; the disease is diabetes mellitus.